National Asset Management, Inc. Humanigen, Inc Transaction History

National Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$3.66 - $8.22 $51,917 - $116,600	-14,185 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$5.93 - $17.83 $30,984 - $93,161	-5,225 Reduced 26.92%	14,185 $85,000
Q2 2021 Aug 10, 2021	BUY	$13.54 - $22.74 $58,357 - $98,009	4,310 Added 28.54%	19,410 $338,000
Q1 2021 May 13, 2021	BUY	$12.91 - $23.83 $194,941 - $359,833	15,100 New	15,100 $289,000

558K

Ticker HGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,661,000
Description
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.